Guadalupe Dominguez, PA
Physician Assistant · North Las Vegas, NVNPI 1649268913
Payments from drug & device makers
Across 244 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$510
- Johnson & Johnson$366
- Sanofi$277
- Gilead$241
- Pfizer$164
- plus $1K from 29 others
What the payments were for
- Food & beverage$4,14598%
- Education$752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,335 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 40 | $510 |
| Johnson & Johnson | 25 | $366 |
| Sanofi | 23 | $277 |
| Gilead | 10 | $241 |
| Pfizer | 7 | $164 |
| Merck | 8 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $124 |
| Aimmune Therapeutics, Inc. | 6 | $119 |
| Novo Nordisk | 6 | $118 |
| Madrigal Pharmaceuticals | 4 | $105 |
| Braintree Laboratories, Inc. | 6 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $62 |
| Boehringer Ingelheim | 2 | $61 |
| Amgen(2 entities) | 3 | $53 |
| Lilly USA, LLC | 3 | $47 |
| AstraZeneca | 3 | $40 |
| Amarin Pharma, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Genentech USA, Inc. | 2 | $23 |
| Ironwood Pharmaceuticals, Inc | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Shield Therapeutics Inc | 1 | $22 |
| GSK | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Orphalan Inc | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Baxter Healthcare | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
| Grifols USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$132
How this compares
$4,220 in reported general payments places this provider in the 85th percentile of 881 physician assistant providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $56,255 |
| TrulicityDulaglutide | 23 | $53,176 |
| TradjentaLinagliptin | 29 | $37,859 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,849 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 18 | $3,123 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 214 | $2,965 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 16 | $2,619 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $2,550 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $2,307 |
| Atorvastatin Calcium | 179 | $1,378 |
| Omeprazole | 217 | $1,361 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 76 | $1,234 |
| Hydrocortisone | 87 | $1,105 |
| Diclofenac Sodium | 28 | $1,086 |
| Gabapentin | 47 | $754 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $61 | $94,11468 claims |
| Lilly USA, LLCTrulicity | $47 | $53,17623 claims |
| AstraZenecaSymbicort | $40 | $3,84912 claims |
| Braintree Laboratories, Inc.Sutab | $93 | $2,61916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 881 physician assistant providers in Nevada.
Other physician assistant in North Las Vegas
- Kyle MachyniaStateline$119K
- Steven HawkesLas Vegas$70K
- John LarsenReno$49K
- Nathan MorganLas Vegas$44K
- Laura BiehleReno$36K
- Benjamin ProhaskaReno$31K
- Adam HarkiewiczHenderson$25K
- Stephanie DastrupLas Vegas$23K
- Sandra OviedoLas Vegas$21K
- Patrick JamesonLas Vegas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.